Last reviewed · How we verify
Direct acting anticoagulant adverse reaction
Approved treatments
- Anxa · Portola Pharamceuticals US
Anxa works by binding to and neutralizing factor Xa inhibitors, reversing anticoagulation. - Andexanet · Portola Pharmaceuticals
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Direct acting anticoagulant adverse reaction patent landscape — cliff calendar, originator estates, attackable patents
- Direct acting anticoagulant adverse reaction treatment landscape brief
- Direct acting anticoagulant adverse reaction treatment updates RSS
Frequently asked questions about Direct acting anticoagulant adverse reaction
What drugs treat Direct acting anticoagulant adverse reaction?
Tracked treatments include Anxa, Andexanet.
What is the treatment for Direct acting anticoagulant adverse reaction?
Standard treatment for Direct acting anticoagulant adverse reaction includes Anxa, Andexanet. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Direct acting anticoagulant adverse reaction patent cliff · Direct acting anticoagulant adverse reaction CI report
- Treatment: Anxa · Portola Pharamceuticals US
- Treatment: Andexanet · Portola Pharmaceuticals
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing